At the recent AI Healthcare Ecological Summit, the Vice President of China’s Jieshou People’s Hospital shared a new disease management system designed to help the nation’s patients deal with chronic health conditions.

AI and wearable devices

Powered by AI, iFLYTECK’s state-of-the-art technology will support effective and efficient monitoring, diagnosis, and treatment of those with chronic diseases.

Given the large portion of the Chinese population who suffer from chronic diseases, the developments are seen as highly significant, especially for the way in which the disease management system will be able to cater to personal needs with a high degree of accuracy.

Officials and care givers hope the offering will bring much-needed disease management relief and effective treatment to a group that has long been underserved.

As the number of patients grow, healthcare needs have increased beyond the capacities of many hospitals. In Jieshou, among the 500,000 residents who are covered by the city’s medical system, there are nearly 73,000 people with hypertension who collectively require 290,000 follow-up visits a year.

To address these extenuating needs, the Jieshou People’s Hospital worked with iFLYTEK Healthcare to develop a digital medical system where artificial intelligence has been adopted to enable automatic hierarchical hypertension management.

Through wearable devices, the digital medical system collects health data from patients in real-time, automatically evaluates their health conditions, and recommends relevant intervention plans.

Through the system, doctors and nurses in Jieshou can focus their attention to the more severely impacted patients, making chronic disease management more efficient and effective, and alleviating the shortage of grassroots general practitioners while better attending to those with hypertension and other chronic diseases.

Since 2018, roughly 7,000 smart blood pressure monitors have been deployed in Jieshou, with 72% of patients with hyperextension covered by the system having since stabilized their conditions.

Thanks to over 1.73 million automatic interventions conducted by the system’s AI smart assistant, the rate of hospitalisation for chronic diseases has been decreasing, reducing the pressure on grassroots medical organizations.

The AI-supported medical system has also provided patients with medical flexibility, aiding in the distribution of effective medical services with a limited number of medical workers.

Through similar collaborative efforts, iFLYTEK Healthcare has committed itself to aid in managing chronic and says it will continue to support the needs of doctors and patients in close coordination with the pressing needs of grass-root medical institutions.